Dermata Therapeutics (NASDAQ:DRMA) Price Target Lowered to $3.00 at Maxim Group
Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) had its price target dropped by stock analysts at Maxim Group from $6.00 to $3.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Maxim Group’s target price indicates a potential upside of 290.63% from […]
Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) had its price target dropped by stock analysts at Maxim Group from $6.00 to $3.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Maxim Group’s target price indicates a potential upside of 290.63% from […]
